Alcoholic hypogonadism: hormonal response to clomiphene

Alcohol
A Martínez-RieraE Rodríguez-Rodríguez

Abstract

To investigate the androgen, weak androgen, estrogen, and gonadotrophin response to clomiphene in alcoholics, we determined in 63 male patients (25 with and 38 without liver cirrhosis) serum testosterone, sexual hormone binding protein (SHBG), dehidroepiandrosterone, androstenedione, LH, FSH, prolactin, and estradiol levels, on the first and the sixth day after admission, and after a course of 8 days of clomiphene 200 mg/day. The same test was performed on 15 healthy volunteers. Cirrhotic patients showed decreased basal testosterone levels and a loss of the circadian rhythm with recovery after clomiphene. Although basal testosterone levels in noncirrhotic alcoholics did not differ from those of the controls, there was a significant improvement after withdrawal. SHBG levels were higher in both groups of alcoholics than in controls, pointing to a worse degree of hypogonadism, because only the free hormone is active. Before the clomiphene test, serum LH and FSH levels were nonsignificantly higher in both groups of alcoholics than in the control group. After clomiphene both LH and FSH increased. Androstenedione and estradiol showed a (parallelism) similar behavior in alcoholic and in cirrhotic groups, showing in both cases higher l...Continue Reading

References

Sep 1, 1975·Metabolism: Clinical and Experimental·D H Van ThielG D Braunstein
Sep 1, 1976·Journal of Studies on Alcohol·M O HuttunenR Ylikahri
Oct 1, 1978·European Journal of Clinical Investigation·J LindholmC Hagen
Jul 1, 1978·Alcoholism, Clinical and Experimental Research·G G GordonC S Lieber
Sep 1, 1978·The Journal of Clinical Endocrinology and Metabolism·D H Van ThielJ Vaitukaitis
Nov 1, 1976·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·L A DistillerM C Kew
Oct 1, 1977·Annals of Internal Medicine·L I RoseG H Williams
Jun 1, 1976·Gut·J R GreenD C Anderson
Sep 1, 1976·The British Journal of Addiction to Alcohol and Other Drugs·J W WrightV Marks
Jun 1, 1975·The Journal of Clinical Endocrinology and Metabolism·G G GordonA L Southren
Sep 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A ZifroniF Schaffner
Nov 1, 1990·Annals of Clinical Biochemistry·C Selby
Jan 1, 1989·Pharmacology & Therapeutics·D H Van ThielR E Tarter
Nov 30, 1987·Drug and Alcohol Dependence·A Castilla-GarcíaL Hernández-Nieto
Nov 1, 1986·Scandinavian Journal of Clinical and Laboratory Investigation·C Gluud, P Bennett
Jul 1, 1985·The Journal of Clinical Endocrinology and Metabolism·H K KleyH L Krüskemper
Feb 1, 1973·The Journal of Clinical Endocrinology and Metabolism·F NaftolinS S Yen
Mar 1, 1973·The Journal of Clinical Endocrinology and Metabolism·R M BoyarL Hellman
May 1, 1973·Metabolism: Clinical and Experimental·A L SouthrenW S Rosenthal
Aug 1, 1973·Annals of Internal Medicine·I J ChopraF L Greenway
Nov 1, 1971·The Journal of Clinical Endocrinology and Metabolism·A VermeulenL Verdonck
Oct 1, 1983·Scandinavian Journal of Gastroenterology·C GluudB Svenstrup
Dec 1, 1981·Fertility and Sterility·R V HaningW E Nolten
Nov 1, 1984·The Journal of Clinical Endocrinology and Metabolism·J P Deslypere, A Vermeulen
Nov 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C M CornelyJ S Gavaler
Nov 1, 1983·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H OrregoA Medline
Jan 1, 1982·Alcoholism, Clinical and Experimental Research·P BertelloA Angeli
Jan 1, 1981·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D H van ThielJ H Lewis
Nov 1, 1982·Clinical Endocrinology·M VälimäkiR Ylikahri
Jan 1, 1980·La Revue de médecine interne·M DecoulxM Linquette
Apr 1, 1994·Current Opinion in Obstetrics & Gynecology·S Franks, C Gilling-Smith
Jul 1, 1993·Environmental Health Perspectives·A Vermeulen

❮ Previous
Next ❯

Citations

Jul 1, 1999·Environmental Health and Preventive Medicine·N ShonoM Nishizumi
Dec 26, 2007·Pathology Oncology Research : POR·Eva RemenárMiklós Kásler
Jan 14, 2003·Fertility and Sterility·Robert S Tan, Deepa Vasudevan
Aug 18, 2001·Journal of Endocrinological Investigation·S Röjdmark, K Brismar
Sep 10, 2013·Endocrinology and Metabolism Clinics of North America·Nadia Rachdaoui, Dipak K Sarkar
Jan 28, 2014·Alcoholism, Clinical and Experimental Research·Kelly KentRuth I Wood
Nov 17, 2016·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Yair Liel
Nov 24, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shuet Fong NeongStephen E Congly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.